Caplin Point listed on Forbes Asia's '200 Best Under a Billion' for 2022

Caplin Point Laboratories Ltd has been selected under Forbes Asia's 200 Best Under a Billion list for 2022. Forbes Asia has selected 200 best performing companies, with revenues of less than a billion, from a list of over 17,000 public listed companies across the Asia-Pacific.

"This is the 5th time in the last 9 years that we've been featured on this prestigious list and is unprecedented for an Indian Pharmaceutical company. We aim for excellence across all aspects of our growth, with a razor sharp focus towards benchmark cashflows and profitability, and this listing is a testament to that." said Mr.C.C.Paarthipan, Chairman, Caplin Point Laboratories, on the listing.

Caplin Point has also been ranked #1 in India for "Most Consistent Profitable Growth across last 10 years" by Value Research magazine in the Wealth Insight June 2022 issue.

Shares of Caplin Point Laboratories Limited was last trading in BSE at Rs. 796.10 as compared to the previous close of Rs. 804.25. The total number of shares traded during the day was 6440 in over 780 trades.

The stock hit an intraday high of Rs. 805.05 and intraday low of 792.65. The net turnover during the day was Rs. 5136577.00.

Source : Equity Bulls

Keywords

CaplinPointLaboratories INE475E01026 Listing ForbesAsia 200BestUnderaBillion